OF CHRONIC B-LYMPHOPROLIFERATIVE DISEASES BY FLOW CYTOMETRY: A LITERATURE REVIEW

2022

Closed access Metadata (CSL-JSON)
DOI 10.52532/2663-4864-2022-2-64-53-58
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Relevance: Immunophenotyping with multiparameter flow cytofluorimetry differentiates classical variants of chronic B-lymphoproliferative diseases. However, some atypical conditions are hard to interpret, leading to the search for new differential markers. The study aimed to analyze the predictive value of monoclonal markers CD200, CD103, and CD11c in differential diagnostics of hairy cell leukemia, splenic marginal zone lymphoma, and splenic mantle zone lymphoma. Methods: We studied open access articles with a search depth of 10 years using the following databases of scientific publications and specialized search engines: PubMed, Google Scholar, Cochrane Library, Web of Science, Scopus, Сyberleninka, and the eLIBRARY electronic library. As a result, 30 literary sources were identified, of which eight publications were the basis of the analytical material for this article. Inclusion criteria: Evidence level A, B publications: meta-analyses, systematic reviews, cohort, and cross-sectional studies. Exclusion criteria: expert opinion in the form of short messages or promotional articles. Results: We revealed a different degree of informativeness of some traditional markers in immunophenotypic diagnostics of B-cell lymphoproliferative diseases by flow cytometry; the use of additional differential markers CD200, CD103, and CD11c showed their high informativeness in differential diagnostics between different variants of B-cell lymphoproliferative diseases with initial immunophenotypic and morphological characteristics of lymphoid elements. Conclusion: Analysis of the selected publications gives grounds to improve the multiparametric panel for differential diagnostics of chronic B-lymphoproliferative diseases.